Vascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response.

ABSTRACT: During tumor growth, angiogenesis is required to ensure oxygen and nutrient transport to the tumor. Vascular endothelial growth factor (VEGF) is the major inducer of angiogenesis and appears to be a key modulator of the anti-tumor immune response. Indeed, VEGF modulates innate and adaptive immune responses through direct interactions and indirectly by modulating protein expressions on endothelial cells or vascular permeability. The inhibition of the VEGF signaling pathway is clinically approved for the treatment of several cancers. Therapies targeting VEGF can modulate the tumor vasculature and the immune response. In this review, we discuss the roles of VEGF in the anti-tumor immune response. In addition, we summarize therapeutic strategies based on its inhibition, and their clinical appr

SUBMITTER: Geindreau M 

PROVIDER: S-EPMC8124522 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature